Cargando…
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
Current drug development in oncology is non-selective as it typically focuses on pathways essential for the survival of all dividing cells. The unique metabolic profile of cancer, which is characterized by increased glycolysis and suppressed mitochondrial glucose oxidation (GO) provides cancer cells...
Autores principales: | Sutendra, Gopinath, Michelakis, Evangelos D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590642/ https://www.ncbi.nlm.nih.gov/pubmed/23471124 http://dx.doi.org/10.3389/fonc.2013.00038 |
Ejemplares similares
-
Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers
por: Jeoung, Nam Ho
Publicado: (2015) -
Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma
por: Kuo, Yu-Hsuan, et al.
Publicado: (2021) -
Pyruvate Dehydrogenase Kinase as a Potential Therapeutic Target for Malignant Gliomas
por: Jha, Mithilesh Kumar, et al.
Publicado: (2013) -
Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer
por: Prakasam, Gopinath, et al.
Publicado: (2018) -
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target
por: HUR, HOON, et al.
Publicado: (2012)